Great Point Partners (GPP), a Greenwich-based private investment firm focused exclusively on the health care industry, has acquired a majority stake in Eutecma, a German-based developer of sustainable, modular, and reusable temperature controlled packaging solutions for pharmaceutical cold chain shipments.

Eutecma produces passive cooling systems that make transport and logistics more sustainable and efficient. The company is a leader in the pharmaceutical industry with its patented ICECATCH cooling systems being a top choice among pharmaceutical, medical, and laboratory diagnostics businesses.

“We have successfully created innovative and sustainable cold chain solutions that have proven themselves with well-known pharmaceutical customers,” said Eutecma Co-Founder, Florian Zeilfelder. “Our work with GPP will advance that mission so we can strategically expand our reach, especially in the US and other geographies around the world.”

With this partnership, Eutecma has also acquired Resolvision, Eutecma’s proprietary re-use machine technology utilized at its Refreshment Centers.

“Eutecma impressed us with their innovative technology and approach to sustainability that is making a significant impact for pharmaceutical clients,” said Eddie Hjerpe, Senior Vice President at GPP. “Their temperature performance, CO2 reduction data, and differentiated engineering is exactly what the evolving cold-chain industry is looking for today.”

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.